Table of Content

Table of Contents

Global Orphan Drug Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Biologics -Product Introduction and Major Manufacturers
1.1.2 Non-Biologics -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Production (2019-2026)
2.2 Regional Market Share in Terms of Revenue (2019-2026)
2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Orphan Drug Market Assessment by Type
3.1 Global Orphan Drug Production by Type (2015-2026)
3.2 Global Orphan Drug Revenue by Type (2015-2026)
3.3 North America Orphan Drug Production and Revenue by Type (2015-2026)
3.4 Asia Orphan Drug Production and Revenue by Type (2015-2026)
3.5 Europe Orphan Drug Production and Revenue by Type (2015-2026)
3.6 Middle East & Africa Orphan Drug Production and Revenue by Type (2015-2026)
3.7 South America Orphan Drug Production and Revenue by Type (2015-2026)

4 Global Orphan Drug Market Assessment by Application
4.1 Historical & Forecast Global Orphan Drug Consumption, Different Application Field (2015-2026)
4.2 Historical & Forecast North America Orphan Drug Consumption, Different Application Field (2015-2026)
4.3 Historical & Forecast Asia Orphan Drug Consumption, Different Application Field (2015-2026)
4.4 Historical & Forecast Europe Orphan Drug Consumption, Different Application Field (2015-2026)
4.5 Historical & Forecast Middle East & Africa Orphan Drug Consumption, Different Application Field (2015-2026)
4.6 Historical & Forecast South America Orphan Drug Consumption, Different Application Field (2015-2026)

5 North America
5.1 US Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.2 Canada Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.3 Mexico Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
6.1 China Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.2 Japan Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.3 India Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.4 Korea Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.5 Southeat Asia Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
7.1 Germany Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.2 UK Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.3 France Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.4 Russia Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.5 Italy Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
8.1 Saudi Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.2 UAE Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.3 Egypt Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.4 Nigeria Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.5 South Africa Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
9.1 Brazil Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.2 Argentina Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.3 Colombia Orphan Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Orphan Drug Average Price Trend
10.1 Market Price for Each Type of Orphan Drug in North America (2015-2026)
10.2 Market Price for Each Type of Orphan Drug in Asia (2015-2026)
10.3 Market Price for Each Type of Orphan Drug in Europe (2015-2026)
10.4 Market Price for Each Type of Orphan Drug in Middle East & Africa (2015-2026)
10.5 Market Price for Each Type of Orphan Drug in South America (2015-2026)

11 Value Chain (Impact of COVID-19)
11.1 Orphan Drug Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Orphan Drug Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors

12 Orphan Drug Competitive Analysis
12.1 AbbVie Inc.
12.1.1 AbbVie Inc. Company Profiles
12.1.2 AbbVie Inc. Product Introduction
12.1.3 AbbVie Inc. Orphan Drug Production, Revenue (2015-2020)
12.1.4 SWOT Analysis
12.2 Aegerion Pharmaceuticals, Inc.
12.2.1 Aegerion Pharmaceuticals, Inc. Company Profiles
12.2.2 Aegerion Pharmaceuticals, Inc. Product Introduction
12.2.3 Aegerion Pharmaceuticals, Inc. Orphan Drug Production, Revenue (2015-2020)
12.2.4 SWOT Analysis
12.3 Bristol-Myers Squibb Company
12.3.1 Bristol-Myers Squibb Company Company Profiles
12.3.2 Bristol-Myers Squibb Company Product Introduction
12.3.3 Bristol-Myers Squibb Company Orphan Drug Production, Revenue (2015-2020)
12.3.4 SWOT Analysis
12.4 Celgene Corporation
12.4.1 Celgene Corporation Company Profiles
12.4.2 Celgene Corporation Product Introduction
12.4.3 Celgene Corporation Orphan Drug Production, Revenue (2015-2020)
12.4.4 SWOT Analysis
12.5 Pfizer Inc.
12.5.1 F. Hoffmann-La Roche Ltd. Company Profiles
12.5.2 F. Hoffmann-La Roche Ltd. Product Introduction
12.5.3 F. Hoffmann-La Roche Ltd. Orphan Drug Production, Revenue (2015-2020)
12.5.4 SWOT Analysis
12.6 GlaxoSmithKline plc
12.6.1 GlaxoSmithKline plc Company Profiles
12.6.2 GlaxoSmithKline plc Product Introduction
12.6.3 GlaxoSmithKline plc Orphan Drug Production, Revenue (2015-2020)
12.6.4 SWOT Analysis
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Profiles
12.7.2 Johnson & Johnson Product Introduction
12.7.3 Johnson & Johnson Orphan Drug Production, Revenue (2015-2020)
12.7.4 SWOT Analysis
12.8 Novartis AG
12.8.1 Novartis AG Company Profiles
12.8.2 Novartis AG Product Introduction
12.8.3 Novartis AG Orphan Drug Production, Revenue (2015-2020)
12.8.4 SWOT Analysis
12.9 Pfizer Inc.
12.9.1 Pfizer Inc. Company Profiles
12.9.2 Pfizer Inc. Product Introduction
12.9.3 Pfizer Inc. Orphan Drug Production, Revenue (2015-2020)
12.9.4 SWOT Analysis
12.10 Sanofi
12.10.1 Sanofi Company Profiles
12.10.2 Sanofi Product Introduction
12.10.3 Sanofi Orphan Drug Production, Revenue (2015-2020)
12.10.4 SWOT Analysis
13 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Orphan Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table Regional Market Share in Terms of Production (2019-2026)
Figure Regional Market Share in Terms of Production (2019 - 2020)
Table Regional Market Share in Terms of Revenue (2019-2026)
Figure Regional Market Share in Terms of Revenue (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Figure Regional Market Share in Terms of Consumption (2019 - 2020)
Table Global Orphan Drug Production (K Unit) by Type (2015-2026)
Figure Global Orphan Drug Production (K Unit) and Growth Rate (2015-2026)
Figure Global Orphan Drug Production Market Share (%) by Type (2019 -2020)
Table Global Orphan Drug Revenue (Million USD) by Type (2015-2026)
Figure Global Orphan Drug Revenue (Million USD) and Growth Rate (2015-2026)
Figure Global Orphan Drug Revenue Market Share (%) by Type (2019-2020)
Figure North America Orphan Drug Production (K Unit) by Type (2015-2026)
Figure North America Orphan Drug Production (K Unit) and Growth Rate (2015-2026)
Figure North America Orphan Drug Revenue (Million USD) by Type (2015-2026)
Figure North America Orphan Drug Revenue (Million USD) and Growth Rate (2015-2026)
Figure Asia Orphan Drug Production (K Unit) by Type (2015-2026)
Figure Asia Orphan Drug Production (K Unit) and Growth Rate (2015-2026)
Figure Asia Orphan Drug Revenue (Million USD) by Type (2015-2026)
Figure Asia Orphan Drug Revenue (Million USD) and Growth Rate (2015-2026)
Figure Europe Orphan Drug Production (K Unit) by Type (2015-2026)
Figure Europe Orphan Drug Production (K Unit) and Growth Rate (2015-2026)
Figure Europe Orphan Drug Revenue (Million USD) by Type (2015-2026)
Figure Europe Orphan Drug Revenue (Million USD) and Growth Rate (2015-2026)
Figure Middle East & Africa Orphan Drug Production (K Unit) by Type (2015-2026)
Figure Middle East & Africa Orphan Drug Production (K Unit) and Growth Rate (2015-2026)
Figure Middle East & Africa Orphan Drug Revenue (Million USD) by Type (2015-2026)
Figure Middle East & Africa Orphan Drug Revenue (Million USD) and Growth Rate (2015-2026)
Figure South America Orphan Drug Production (K Unit) by Type (2015-2026)
Figure South America Orphan Drug Production (K Unit) and Growth Rate (2015-2026)
Figure South America Orphan Drug Revenue (Million USD) by Type (2015-2026)
Figure South America Orphan Drug Revenue (Million USD) and Growth Rate (2015-2026)
Table Historical & Forecast Orphan Drug Different Application Field Consumption (K Unit)
Figure Consumption (K Unit) and Growth Rate (2015-2026)
Figure Different Application Field Consumption Market Share (%) (2019-2020)
Table Historical & Forecast Orphan Drug Different Application Field Consumption (K Unit)
Figure North America Orphan Drug Consumption (K Unit) and Growth Rate (2015-2026)
Figure North America Orphan Drug Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Orphan Drug Different Application Field Consumption (K Unit)
Figure Asia Orphan Drug Consumption (K Unit) and Growth Rate (2015-2026)
Figure Asia Orphan Drug Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Orphan Drug Different Application Field Consumption (K Unit)
Figure Europe Orphan Drug Consumption (K Unit) and Growth Rate (2015-2026)
Figure Europe Orphan Drug Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Orphan Drug Different Application Field Consumption (K Unit)
Figure Middle East & Africa Orphan Drug Consumption (K Unit) and Growth Rate (2015-2026)
Figure Middle East & Africa Orphan Drug Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Orphan Drug Different Application Field Consumption (K Unit)
Figure South America Orphan Drug Consumption (K Unit) and Growth Rate (2015-2026)
Figure South America Orphan Drug Consumption Market Share (%) by Application (2015-2026)
Table Historical & Forecast Orphan Drug Different Application Field Consumption (K Unit)
Table US Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Canada Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Mexico Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table China Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Japan Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table India Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Korea Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Southeast Asia Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Germany Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UK Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table France Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Russia Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Italy Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Saudi Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table UAE Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Egypt Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Nigeria Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table South Africa Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Brazil Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Argentina Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Colombia Orphan Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
Figure Proportion of Products Sold (%) (2015 -2026)
Table Market Price (USD/Unit) for Each Type of Orphan Drug in China
Table Market Price (USD/Unit) for Each Type of Orphan Drug in EU
Table Market Price (USD/Unit) for Each Type of Orphan Drug in USA
Table Market Price (USD/Unit) for Each Type of Orphan Drug in Japan
Table Market Price (USD/Unit) for Each Type of Orphan Drug in India
Table Market Price (USD/Unit) for Each Type of Orphan Drug in Southeast Asia
Table Market Price (USD/Unit) for Each Type of Orphan Drug in South America
Figure Value Chain Structure of Orphan Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Orphan Drug
Figure Cost Structure of Orphan Drug in 2020
Table Distributors/Traders List
Table AbbVie Inc. Profiles
Table AbbVie Inc. Orphan Drug Product Introduction
Figure AbbVie Inc. Orphan Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure AbbVie Inc. SWOT Analysis
Table Aegerion Pharmaceuticals, Inc. Profiles
Table Aegerion Pharmaceuticals, Inc. Orphan Drug Product Introduction
Figure Aegerion Pharmaceuticals, Inc. Orphan Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Aegerion Pharmaceuticals, Inc. SWOT Analysis
Table Bristol-Myers Squibb Company Profiles
Table Bristol-Myers Squibb Company Orphan Drug Product Introduction
Figure Bristol-Myers Squibb Company Orphan Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Bristol-Myers Squibb Company SWOT Analysis
Table Celgene Corporation Profiles
Table Celgene Corporation Orphan Drug Product Introduction
Figure Celgene Corporation Orphan Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Celgene Corporation SWOT Analysis
Table F. Hoffmann-La Roche Ltd. Profiles
Table F. Hoffmann-La Roche Ltd. Orphan Drug Product Introduction
Figure F. Hoffmann-La Roche Ltd. Pharma & Healthcare Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure F. Hoffmann-La Roche Ltd. SWOT Analysis
Table GlaxoSmithKline plc Profiles
Table GlaxoSmithKline plc Orphan Drug Product Introduction
Figure GlaxoSmithKline plc Orphan Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure GlaxoSmithKline plc SWOT Analysis
Table Johnson & Johnson Profiles
Table Johnson & Johnson Orphan Drug Product Introduction
Figure Johnson & Johnson Orphan Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Johnson & Johnson SWOT Analysis
Table Novartis AG Profiles
Table Novartis AG Orphan Drug Product Introduction
Figure Novartis AG Orphan Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Novartis AG SWOT Analysis
Table Pfizer Inc. Profiles
Table Pfizer Inc. Orphan Drug Product Introduction
Figure Pfizer Inc. Orphan Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Figure Pfizer Inc. SWOT Analysis
Table Sanofi Profiles
Table Sanofi Orphan Drug Product Introduction
Figure Sanofi Orphan Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)